User profiles for R. Hodge

Rebecca D Hodge

Allen Institute for Brain Science
Verified email at alleninstitute.org
Cited by 9521

Regulating Rho GTPases and their regulators

RG Hodge, AJ Ridley - Nature reviews Molecular cell biology, 2016 - nature.com
Rho GTPases regulate cytoskeletal and cell adhesion dynamics and thereby coordinate a
wide range of cellular processes, including cell migration, cell polarity and cell cycle …

Transcription factors in glutamatergic neurogenesis: conserved programs in neocortex, cerebellum, and adult hippocampus

RF Hevner, RD Hodge, RAM Daza, C Englund - Neuroscience research, 2006 - Elsevier
Glutamatergic, pyramidal-projection neurons are produced in the embryonic cerebral cortex
by a series of genetically programmed fate choices, implemented in large part by …

[HTML][HTML] A community-based transcriptomics classification and nomenclature of neocortical cell types

…, J Hjerling-Leffler, R Hodge, J Huang, R Huda… - Nature …, 2020 - nature.com
To understand the function of cortical circuits, it is necessary to catalog their cellular diversity.
Past attempts to do so using anatomical, physiological or molecular features of cortical …

[BOOK][B] Social semiotics

RIV Hodge, GR Kress - 1988 - books.google.com
Semiotics was defined by Ferdinand de Saussure as" the science of the life of signs in
society." Robert Hodge and Gunther Kress here confront the conceptual difficulties that have …

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

…, IR Judson, N Araki, M Ouali, S Marreaud, R Hodge… - The Lancet, 2012 - thelancet.com
Background Pazopanib, a multitargeted tyrosine kinase inhibitor, has single-agent activity in
patients with advanced non-adipocytic soft-tissue sarcoma. We investigated the effect of …

[HTML][HTML] Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

…, WC Su, JE Gray, SM Lee, R Hodge… - New England journal …, 2018 - Mass Medical Soc
Background Osimertinib is an oral, third-generation, irreversible epidermal growth factor
receptor tyrosine kinase inhibitor (EGFR-TKI) that selectively inhibits both EGFR-TKI–sensitizing …

[HTML][HTML] Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

…, F Imamura, T Kurata, A Todd, R Hodge… - … England Journal of …, 2020 - Mass Medical Soc
Background Osimertinib is a third-generation, irreversible tyrosine kinase inhibitor of the
epidermal growth factor receptor (EGFR-TKI) that selectively inhibits both EGFR-TKI–sensitizing …

Conserved cell types with divergent features in human versus mouse cortex

RD Hodge, TE Bakken, JA Miller, KA Smith, ER Barkan… - Nature, 2019 - nature.com
Elucidating the cellular architecture of the human cerebral cortex is central to understanding
our cognitive abilities and susceptibility to disease. Here we used single-nucleus RNA-…

[HTML][HTML] Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

…, FA Shepherd, L Zeng, R Hodge… - … England Journal of …, 2020 - Mass Medical Soc
Background Osimertinib is standard-of-care therapy for previously untreated epidermal
growth factor receptor (EGFR) mutation–positive advanced non–small-cell lung cancer (NSCLC). …

[HTML][HTML] Comparative cellular analysis of motor cortex in human, marmoset and mouse

…, BB Lake, W Tian, BE Kalmbach, M Crow, RD Hodge… - Nature, 2021 - nature.com
The primary motor cortex (M1) is essential for voluntary fine-motor control and is functionally
conserved across mammals 1 . Here, using high-throughput transcriptomic and epigenomic …